As a result of naturally occurring commensal infections, over half of all people studied have pre-existing adaptive immunity to CRISPR. This may potentially limit the utility of CRISPR as it moves into human clinical trials.

See the source article by following the link below:
As a result of naturally occurring commensal infections, over half of all people studied have pre-existing adaptive immunity to CRISPR. This may potentially limit the utility of CRISPR as it moves into human clinical trials.